Sinil Pharmaceutical Co. Ltd Asset Resilience Ratio

Latest as of September 2025: 17.46%

Sinil Pharmaceutical Co. Ltd asset resilience ratio. Sinil Pharmaceutical Co. Ltd (012790) has an Asset Resilience Ratio of 17.46% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Sinil Pharmaceutical Co. Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩29.67 Billion

≈ $20.11 Million USD Cash + Short-term Investments

Total Assets

₩169.94 Billion

≈ $115.16 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Sinil Pharmaceutical Co. Ltd (2014–2024)

Asset resilience ratio of Sinil Pharmaceutical Co. Ltd from 2014 to 2024. This chart shows how Sinil Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Sinil Pharmaceutical Co. Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sinil Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 012790 current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩29.67 Billion	17.46%
Total Liquid Assets	₩29.67 Billion	17.46%

Asset Resilience Insights

Good Liquidity Position: Sinil Pharmaceutical Co. Ltd maintains a healthy 17.46% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Sinil Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Sinil Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Sinil Pharmaceutical Co. Ltd Asset Resilience Ratio by Year (2014–2024)

Sinil Pharmaceutical Co. Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Sinil Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	20.31%	₩33.69 Billion ≈ $22.83 Million	₩165.86 Billion ≈ $112.40 Million	+4.96pp
2023-12-31	15.35%	₩23.41 Billion ≈ $15.86 Million	₩152.46 Billion ≈ $103.32 Million	-0.97pp
2022-12-31	16.32%	₩23.31 Billion ≈ $15.80 Million	₩142.83 Billion ≈ $96.79 Million	+0.16pp
2021-12-31	16.16%	₩20.84 Billion ≈ $14.12 Million	₩128.97 Billion ≈ $87.40 Million	+4.48pp
2020-12-31	11.68%	₩14.57 Billion ≈ $9.88 Million	₩124.81 Billion ≈ $84.58 Million	+0.17pp
2019-12-31	11.50%	₩13.56 Billion ≈ $9.19 Million	₩117.84 Billion ≈ $79.86 Million	-1.32pp
2018-12-31	12.83%	₩13.65 Billion ≈ $9.25 Million	₩106.40 Billion ≈ $72.11 Million	-0.10pp
2017-12-31	12.93%	₩13.25 Billion ≈ $8.98 Million	₩102.52 Billion ≈ $69.48 Million	-1.86pp
2016-12-31	14.79%	₩14.50 Billion ≈ $9.83 Million	₩98.05 Billion ≈ $66.45 Million	-2.98pp
2015-12-31	17.77%	₩15.51 Billion ≈ $10.51 Million	₩87.26 Billion ≈ $59.14 Million	-0.66pp
2014-12-31	18.43%	₩14.73 Billion ≈ $9.98 Million	₩79.91 Billion ≈ $54.15 Million	--

pp = percentage points

About Sinil Pharmaceutical Co. Ltd

KQ:012790 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$49.12 Million

₩72.48 Billion KRW

Market Cap Rank

#21782 Global

#1317 in Korea

Share Price

₩6270.00

Change (1 day)

+0.80%

52-Week Range

₩4900.00 - ₩6530.00

All Time High

₩50717.45